Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1992 1
1993 1
1995 1
1997 3
1998 4
2002 1
2003 3
2004 1
2005 1
2007 1
2008 5
2009 5
2010 2
2011 7
2012 7
2013 8
2014 6
2015 8
2016 4
2017 9
2018 7
2019 8
2020 11
2021 10
2022 10
2023 4
2024 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122 results

Results by year

Filters applied: . Clear all
Page 1
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial.
Schlaich MP, Bellet M, Weber MA, Danaietash P, Bakris GL, Flack JM, Dreier RF, Sassi-Sayadi M, Haskell LP, Narkiewicz K, Wang JG; PRECISION investigators. Schlaich MP, et al. Lancet. 2022 Dec 3;400(10367):1927-1937. doi: 10.1016/S0140-6736(22)02034-7. Epub 2022 Nov 7. Lancet. 2022. PMID: 36356632 Clinical Trial.
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR; CANVAS Program Collaborative Group. Neal B, et al. N Engl J Med. 2017 Aug 17;377(7):644-657. doi: 10.1056/NEJMoa1611925. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605608 Free article. Clinical Trial.
[2022 Practice guidelines for the management of arterial hypertension of the Spanish Society of Hypertension].
Gorostidi M, Gijón-Conde T, de la Sierra A, Rodilla E, Rubio E, Vinyoles E, Oliveras A, Santamaría R, Segura J, Molinero A, Pérez-Manchón D, Abad M, Abellán J, Armario P, Banegas JR, Camafort M, Catalina C, Coca A, Divisón JA, Domenech M, Martell N, Martín-Rioboó E, Morales-Olivas F, Pallarés V, Pérez de Isla L, Prieto MA, Redón J, Ruilope LM, García-Donaire JA. Gorostidi M, et al. Among authors: oliveras a. Hipertens Riesgo Vasc. 2022 Oct-Dec;39(4):174-194. doi: 10.1016/j.hipert.2022.09.002. Epub 2022 Sep 22. Hipertens Riesgo Vasc. 2022. PMID: 36153303 Spanish.
Reply.
de la Sierra A, Oliveras A, Armario P, Fernández-Llama P. de la Sierra A, et al. Among authors: oliveras a. J Hypertens. 2017 Nov;35(11):2324-2325. doi: 10.1097/HJH.0000000000001522. J Hypertens. 2017. PMID: 28953592 No abstract available.
Screening and diagnosis of primary aldosteronism. Consensus document of all the Spanish Societies involved in the management of primary aldosteronism.
Araujo-Castro M, Ruiz-Sánchez JG, Parra Ramírez P, Martín Rojas-Marcos P, Aguilera-Saborido A, Gómez Cerezo JF, López Lazareno N, Torregrosa Quesada ME, Gorrin Ramos J, Oriola J, Poch E, Oliveras A, Méndez Monter JV, Gómez Muriel I, Bella-Cueto MR, Mercader Cidoncha E, Runkle I, Hanzu FA; In representation of the following medical Spanish societies: Spanish Society of Endocrinology and Nutrition (SEEN), Spanish Society of Cardiology (SEC), Spanish Society of Nephrology (SEN), Spanish Society of Internal Medicine (SEMI), Spanish Radiology Society (SERAM), Spanish Society of Vascular and Interventional Radiology (SERVEI), Spanish Society of Laboratory Medicine (SEQC(ML), Spanish Society of Anatomic-Pathology, Spanish Association of Surgeons (AEC). Araujo-Castro M, et al. Among authors: oliveras a. Endocrine. 2024 Jul;85(1):99-121. doi: 10.1007/s12020-024-03751-1. Epub 2024 Mar 6. Endocrine. 2024. PMID: 38448679 Review.
Practical consensus for the treatment and follow-up of primary aldosteronism: a multidisciplinary consensus document.
Araujo-Castro M, Ruiz-Sánchez JG, Ramírez PP, Martín Rojas-Marcos P, Aguilera-Saborido A, Gómez Cerezo JF, López Lazareno N, Torregrosa ME, Gorrín Ramos J, Oriola J, Poch E, Oliveras A, Méndez Monter JV, Gómez Muriel I, Bella-Cueto MR, Mercader Cidoncha E, Runkle I, Hanzu FA. Araujo-Castro M, et al. Among authors: oliveras a. Endocrine. 2024 Aug;85(2):532-544. doi: 10.1007/s12020-024-03773-9. Epub 2024 Mar 20. Endocrine. 2024. PMID: 38507182 Review.
New therapeutic targets in hypertension.
de la Sierra A, Oliveras A. de la Sierra A, et al. Among authors: oliveras a. Med Clin (Barc). 2024 Sep 27;163(6):301-305. doi: 10.1016/j.medcli.2024.03.028. Epub 2024 Jun 6. Med Clin (Barc). 2024. PMID: 38849267 Review. English, Spanish.
Bariatric Surgery and Hypertension.
Climent E, Oliveras A, Pedro-Botet J, Goday A, Benaiges D. Climent E, et al. Among authors: oliveras a. J Clin Med. 2021 Sep 7;10(18):4049. doi: 10.3390/jcm10184049. J Clin Med. 2021. PMID: 34575161 Free PMC article. Review.
[Thoracic actinomycosis].
Ibáñez-Nolla J, Carratalá J, Cucurull J, Corbella X, Oliveras A, Curull V, Liñares J, Gudiol F. Ibáñez-Nolla J, et al. Among authors: oliveras a. Enferm Infecc Microbiol Clin. 1993 Oct;11(8):433-6. Enferm Infecc Microbiol Clin. 1993. PMID: 8260516 Review. Spanish.
122 results